Risk factors for subtherapeutic levels of posaconazole tablet.


Background Posaconazole is the prophylactic antifungal of choice for patients with haematological malignancies at high risk of invasive fungal infections (IFIs). Studies have demonstrated that subtherapeutic concentrations of posaconazole are associated with breakthrough fungal infections and specific risk factors for subtherapeutic troughs associated with… (More)
DOI: 10.1093/jac/dkx228